GenCell BioSystems Ltd. ("GenCell") is an innovative lifesciences technology company. Its CLiC system fully automates library preparation for next-generation DNA sequencing using proprietary composite liquid cell technology.

The technology has multiple applications across drug discovery, agricultural biotechnology, medical genomics, molecular diagnostics and synthetic biology. Pegasus Capital advised on the company on a series A fundraising with private investors.

The funds raised were used for research & development and to fully commercialise GenCell BioSystem's technology.

www.bd.com